Search Results

As companies invest billions of dollars to reshore manufacturing, 10 biotech and pharma businesses are reportedly trimming staff at manufacturing locations in 2026 or the coming years, with BioNTech having the deepest cuts.

Learn what manufacturing challenges lie ahead, how to equip your team to protect your program from avoidable manufacturing and regulatory setbacks and forge partnerships that can withstand the next five years of industry turbulence.

While AI is taking off in biopharma for administrative tasks and drug discovery efforts, more than 90% of drugmakers have yet to commit to scaling AI use in regulated biopharma manufacturing, according to CRB’s new Horizons: Life Sciences report.

The new site strengthens the company’s production capacity, sustainable industrial footprint, and support for global bioprocessing customers. • New 4,200 m² headquarters and manufacturing facility located within the Biopôle Clermont-Limagne life sciences technology park • Designed to increase manufacturing capacity by 150% for the company’s downstream purification technologies • Selected as part of the France 2030 “Industrialization and Health Capacities 2030” program • Sustainable features include photovoltaic panels, green roofing, rainwater recovery and reuse, and electric vehicle charging stations